Stock Price & Analysis

The S1 support level for RCEL Stock is $8.41 ,The R1 resistant level for RCEL Stock is $9.91.

As of the end of day on 2025-01-23, the price of RCEL Stock was $9.06.

The target price for RCEL Stock according to analyst rating is 17.40, with the highest price target at 25.00 and the lowest at 12.00. Analysts have a Moderate Buy rating on RCEL Stock overall.

The market cap of RCEL is $234.6M.

AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators. RECELL is used for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. The platform technology of the RECELL System enables a thin split-thickness skin sample from the patient to be processed and prepared, producing an autologous cellular suspension called Spray-On Skin Cells. These Spray-On Skin Cells are prepared at the point of care in as little as 30 minutes, providing a new way to treat thermal burn wounds and full-thickness skin defects.

RCEL has a total of 207 employees.